
Hamilton Thorne Investor Relations Material
Latest events

Q1 2024
Hamilton Thorne

Q3 2024
13 Nov, 2024

Q2 2024
14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hamilton Thorne Ltd
Access all reports
Hamilton Thorne is a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets. It sells its products and services to infertility clinics, university research centers, large animal breeding facilities, pharmaceutical firms, biotechnology companies and other commercial and academic research establishments. The company provides novel solutions for Life Science that reduce cost, increase productivity improve results and enable rapid progress in scientific research from basic biology through translational research.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
HTL
Country
🇨🇦 Canada